31
Participants
Start Date
September 1, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Natural Killer Cells
NK cells dose 1x 108 cells/ kg on day 8 of each cycle
Temozolomide
Temozolomide 100mg/m2/dose PO or IV daily on Days 1-5; if given orally, must be at least one hour prior to Irinotecan. For patients whose body surface area is \<0.5m2, temozolomide dosing is based on body weight in (kg), at a dose of 3.3 mg/kg/dose.
Irinotecan
Irinotecan 50mg/m2/dose IV daily on Days 1-5
Dinutuximab
Dinutuximab 17.5mg/m2/dose IV daily on Days 2-5
Sargramostim
Sargramostim 250mcg/m2/dose subcutaneous daily on Days 6-12
RECRUITING
Nationwide Children's Hospital, Columbus
Nationwide Children's Hospital
OTHER